Lucid Diagnostics Files Prospectus Supplement
Ticker: LUCD · Form: 424B5 · Filed: Apr 23, 2026 · CIK: 0001799011
Sentiment: neutral
Topics: prospectus, offering, securities
TL;DR
Lucid Diagnostics dropped a prospectus supplement on 4/23/26 for a stock offering. Watch for dilution!
AI Summary
Lucid Diagnostics Inc. filed a 424B5 prospectus supplement on April 23, 2026, related to its common stock. The filing details the terms of a proposed offering, including the number of shares and the price range, which are crucial for investors to understand the potential dilution and capital raised by the company.
Why It Matters
This filing provides potential investors with updated information regarding a securities offering, impacting the company's capital structure and share availability.
Risk Assessment
Risk Level: medium — Prospectus supplements often indicate a company is seeking to raise capital, which can lead to dilution for existing shareholders.
Key Numbers
- 704843 — Document Size (form424b5.htm) (Size of the main prospectus filing document.)
- 710222 — Document Size (Complete submission text file) (Size of the full submission text file.)
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Filer of the 424B5 form
- 0001799011 (company) — CIK number for Lucid Diagnostics Inc.
- 2026-04-23 (date) — Filing date of the 424B5 form
- 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 (address) — Mailing and Business Address for Lucid Diagnostics Inc.
FAQ
What type of filing is this 424B5?
This is a Prospectus [Rule 424(b)(5)] filing.
Who is the filer of this document?
The filer is Lucid Diagnostics Inc. (CIK: 0001799011).
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-23.
What is the business address listed for Lucid Diagnostics Inc.?
The business address is 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017.
What is the SIC code for Lucid Diagnostics Inc.?
The SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 424B5 (Form 424B5) was filed with the SEC on April 23, 2026 regarding Lucid Diagnostics Inc. (LUCD).